nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—CYP3A4—Everolimus—kidney cancer	0.127	0.293	CbGbCtD
Etonogestrel—CYP3A4—Temsirolimus—kidney cancer	0.0857	0.198	CbGbCtD
Etonogestrel—CYP3A4—Pazopanib—kidney cancer	0.045	0.104	CbGbCtD
Etonogestrel—CYP3A4—Erlotinib—kidney cancer	0.0321	0.0741	CbGbCtD
Etonogestrel—CYP3A4—Paclitaxel—kidney cancer	0.0294	0.0678	CbGbCtD
Etonogestrel—CYP3A4—Sorafenib—kidney cancer	0.0261	0.0603	CbGbCtD
Etonogestrel—CYP3A4—Vinblastine—kidney cancer	0.0258	0.0595	CbGbCtD
Etonogestrel—CYP3A4—Vincristine—kidney cancer	0.0253	0.0585	CbGbCtD
Etonogestrel—CYP3A4—Sunitinib—kidney cancer	0.0212	0.0488	CbGbCtD
Etonogestrel—CYP3A4—Doxorubicin—kidney cancer	0.0158	0.0366	CbGbCtD
Etonogestrel—Ill-defined disorder—Paclitaxel—kidney cancer	0.000287	0.000598	CcSEcCtD
Etonogestrel—Connective tissue disorder—Capecitabine—kidney cancer	0.000287	0.000597	CcSEcCtD
Etonogestrel—Vomiting—Everolimus—kidney cancer	0.000286	0.000596	CcSEcCtD
Etonogestrel—Urethral disorder—Capecitabine—kidney cancer	0.000286	0.000596	CcSEcCtD
Etonogestrel—Paraesthesia—Vincristine—kidney cancer	0.000286	0.000595	CcSEcCtD
Etonogestrel—Rash—Everolimus—kidney cancer	0.000284	0.000591	CcSEcCtD
Etonogestrel—Dermatitis—Everolimus—kidney cancer	0.000284	0.000591	CcSEcCtD
Etonogestrel—Headache—Vinblastine—kidney cancer	0.000283	0.00059	CcSEcCtD
Etonogestrel—Angioedema—Paclitaxel—kidney cancer	0.000283	0.000589	CcSEcCtD
Etonogestrel—Headache—Everolimus—kidney cancer	0.000282	0.000587	CcSEcCtD
Etonogestrel—Abdominal pain—Dactinomycin—kidney cancer	0.000282	0.000586	CcSEcCtD
Etonogestrel—Body temperature increased—Dactinomycin—kidney cancer	0.000282	0.000586	CcSEcCtD
Etonogestrel—Visual impairment—Capecitabine—kidney cancer	0.000281	0.000586	CcSEcCtD
Etonogestrel—Asthenia—Sorafenib—kidney cancer	0.000281	0.000584	CcSEcCtD
Etonogestrel—Malaise—Paclitaxel—kidney cancer	0.000279	0.000581	CcSEcCtD
Etonogestrel—Hypersensitivity—Sunitinib—kidney cancer	0.000277	0.000577	CcSEcCtD
Etonogestrel—Decreased appetite—Vincristine—kidney cancer	0.000277	0.000576	CcSEcCtD
Etonogestrel—Pruritus—Sorafenib—kidney cancer	0.000277	0.000576	CcSEcCtD
Etonogestrel—Vomiting—Erlotinib—kidney cancer	0.000276	0.000575	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000275	0.000572	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Vincristine—kidney cancer	0.000275	0.000572	CcSEcCtD
Etonogestrel—Fatigue—Vincristine—kidney cancer	0.000274	0.000571	CcSEcCtD
Etonogestrel—Rash—Erlotinib—kidney cancer	0.000274	0.00057	CcSEcCtD
Etonogestrel—Dermatitis—Erlotinib—kidney cancer	0.000274	0.00057	CcSEcCtD
Etonogestrel—Insomnia—Gemcitabine—kidney cancer	0.000273	0.000568	CcSEcCtD
Etonogestrel—Eye disorder—Capecitabine—kidney cancer	0.000273	0.000568	CcSEcCtD
Etonogestrel—Headache—Erlotinib—kidney cancer	0.000272	0.000567	CcSEcCtD
Etonogestrel—Pain—Vincristine—kidney cancer	0.000272	0.000566	CcSEcCtD
Etonogestrel—Constipation—Vincristine—kidney cancer	0.000272	0.000566	CcSEcCtD
Etonogestrel—Pain in extremity—Doxorubicin—kidney cancer	0.000272	0.000566	CcSEcCtD
Etonogestrel—Paraesthesia—Gemcitabine—kidney cancer	0.000271	0.000564	CcSEcCtD
Etonogestrel—Cough—Paclitaxel—kidney cancer	0.00027	0.000562	CcSEcCtD
Etonogestrel—Asthenia—Sunitinib—kidney cancer	0.00027	0.000562	CcSEcCtD
Etonogestrel—Nausea—Vinblastine—kidney cancer	0.000269	0.000559	CcSEcCtD
Etonogestrel—Somnolence—Gemcitabine—kidney cancer	0.000268	0.000559	CcSEcCtD
Etonogestrel—Convulsion—Paclitaxel—kidney cancer	0.000268	0.000558	CcSEcCtD
Etonogestrel—Migraine—Doxorubicin—kidney cancer	0.000268	0.000557	CcSEcCtD
Etonogestrel—Affect lability—Doxorubicin—kidney cancer	0.000268	0.000557	CcSEcCtD
Etonogestrel—Nausea—Everolimus—kidney cancer	0.000268	0.000557	CcSEcCtD
Etonogestrel—Diarrhoea—Sorafenib—kidney cancer	0.000268	0.000557	CcSEcCtD
Etonogestrel—Hypertension—Paclitaxel—kidney cancer	0.000267	0.000556	CcSEcCtD
Etonogestrel—Pruritus—Sunitinib—kidney cancer	0.000266	0.000554	CcSEcCtD
Etonogestrel—Angiopathy—Capecitabine—kidney cancer	0.000265	0.000551	CcSEcCtD
Etonogestrel—Immune system disorder—Capecitabine—kidney cancer	0.000264	0.000549	CcSEcCtD
Etonogestrel—Arthralgia—Paclitaxel—kidney cancer	0.000264	0.000549	CcSEcCtD
Etonogestrel—Myalgia—Paclitaxel—kidney cancer	0.000264	0.000549	CcSEcCtD
Etonogestrel—Anxiety—Paclitaxel—kidney cancer	0.000263	0.000547	CcSEcCtD
Etonogestrel—Decreased appetite—Gemcitabine—kidney cancer	0.000262	0.000546	CcSEcCtD
Etonogestrel—Hypersensitivity—Dactinomycin—kidney cancer	0.000262	0.000546	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000262	0.000545	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000261	0.000542	CcSEcCtD
Etonogestrel—Discomfort—Paclitaxel—kidney cancer	0.000261	0.000542	CcSEcCtD
Etonogestrel—Fatigue—Gemcitabine—kidney cancer	0.00026	0.000542	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Vincristine—kidney cancer	0.00026	0.000542	CcSEcCtD
Etonogestrel—Dizziness—Sorafenib—kidney cancer	0.000259	0.000538	CcSEcCtD
Etonogestrel—Pain—Gemcitabine—kidney cancer	0.000258	0.000537	CcSEcCtD
Etonogestrel—Constipation—Gemcitabine—kidney cancer	0.000258	0.000537	CcSEcCtD
Etonogestrel—Nausea—Erlotinib—kidney cancer	0.000258	0.000537	CcSEcCtD
Etonogestrel—Alopecia—Capecitabine—kidney cancer	0.000258	0.000537	CcSEcCtD
Etonogestrel—Mood swings—Doxorubicin—kidney cancer	0.000258	0.000536	CcSEcCtD
Etonogestrel—Diarrhoea—Sunitinib—kidney cancer	0.000257	0.000536	CcSEcCtD
Etonogestrel—Mental disorder—Capecitabine—kidney cancer	0.000256	0.000532	CcSEcCtD
Etonogestrel—Asthenia—Dactinomycin—kidney cancer	0.000256	0.000532	CcSEcCtD
Etonogestrel—Malnutrition—Capecitabine—kidney cancer	0.000254	0.000529	CcSEcCtD
Etonogestrel—Erythema—Capecitabine—kidney cancer	0.000254	0.000529	CcSEcCtD
Etonogestrel—Anaphylactic shock—Paclitaxel—kidney cancer	0.000253	0.000526	CcSEcCtD
Etonogestrel—Oedema—Paclitaxel—kidney cancer	0.000253	0.000526	CcSEcCtD
Etonogestrel—Abdominal pain—Vincristine—kidney cancer	0.000252	0.000524	CcSEcCtD
Etonogestrel—Body temperature increased—Vincristine—kidney cancer	0.000252	0.000524	CcSEcCtD
Etonogestrel—Infection—Paclitaxel—kidney cancer	0.000251	0.000523	CcSEcCtD
Etonogestrel—Flatulence—Capecitabine—kidney cancer	0.00025	0.000521	CcSEcCtD
Etonogestrel—Dizziness—Sunitinib—kidney cancer	0.000249	0.000518	CcSEcCtD
Etonogestrel—Feeling abnormal—Gemcitabine—kidney cancer	0.000249	0.000518	CcSEcCtD
Etonogestrel—Vomiting—Sorafenib—kidney cancer	0.000249	0.000517	CcSEcCtD
Etonogestrel—Nervous system disorder—Paclitaxel—kidney cancer	0.000248	0.000516	CcSEcCtD
Etonogestrel—Rash—Sorafenib—kidney cancer	0.000247	0.000513	CcSEcCtD
Etonogestrel—Dermatitis—Sorafenib—kidney cancer	0.000246	0.000513	CcSEcCtD
Etonogestrel—Back pain—Capecitabine—kidney cancer	0.000246	0.000512	CcSEcCtD
Etonogestrel—Breast disorder—Doxorubicin—kidney cancer	0.000246	0.000512	CcSEcCtD
Etonogestrel—Skin disorder—Paclitaxel—kidney cancer	0.000246	0.000511	CcSEcCtD
Etonogestrel—Headache—Sorafenib—kidney cancer	0.000245	0.00051	CcSEcCtD
Etonogestrel—Muscle spasms—Capecitabine—kidney cancer	0.000244	0.000509	CcSEcCtD
Etonogestrel—Diarrhoea—Dactinomycin—kidney cancer	0.000244	0.000507	CcSEcCtD
Etonogestrel—Anorexia—Paclitaxel—kidney cancer	0.000241	0.000501	CcSEcCtD
Etonogestrel—Gastritis—Doxorubicin—kidney cancer	0.000241	0.000501	CcSEcCtD
Etonogestrel—Vomiting—Sunitinib—kidney cancer	0.000239	0.000498	CcSEcCtD
Etonogestrel—Body temperature increased—Gemcitabine—kidney cancer	0.000239	0.000497	CcSEcCtD
Etonogestrel—Rash—Sunitinib—kidney cancer	0.000237	0.000494	CcSEcCtD
Etonogestrel—Dermatitis—Sunitinib—kidney cancer	0.000237	0.000493	CcSEcCtD
Etonogestrel—Abdominal distension—Doxorubicin—kidney cancer	0.000237	0.000493	CcSEcCtD
Etonogestrel—Ill-defined disorder—Capecitabine—kidney cancer	0.000236	0.000491	CcSEcCtD
Etonogestrel—Headache—Sunitinib—kidney cancer	0.000236	0.000491	CcSEcCtD
Etonogestrel—Asthma—Doxorubicin—kidney cancer	0.000235	0.000489	CcSEcCtD
Etonogestrel—Hypersensitivity—Vincristine—kidney cancer	0.000234	0.000488	CcSEcCtD
Etonogestrel—Nausea—Sorafenib—kidney cancer	0.000232	0.000483	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00023	0.000479	CcSEcCtD
Etonogestrel—Malaise—Capecitabine—kidney cancer	0.000229	0.000477	CcSEcCtD
Etonogestrel—Insomnia—Paclitaxel—kidney cancer	0.000229	0.000476	CcSEcCtD
Etonogestrel—Asthenia—Vincristine—kidney cancer	0.000228	0.000475	CcSEcCtD
Etonogestrel—Paraesthesia—Paclitaxel—kidney cancer	0.000227	0.000472	CcSEcCtD
Etonogestrel—Vomiting—Dactinomycin—kidney cancer	0.000226	0.000471	CcSEcCtD
Etonogestrel—Bronchitis—Doxorubicin—kidney cancer	0.000226	0.000471	CcSEcCtD
Etonogestrel—Somnolence—Paclitaxel—kidney cancer	0.000225	0.000468	CcSEcCtD
Etonogestrel—Rash—Dactinomycin—kidney cancer	0.000225	0.000467	CcSEcCtD
Etonogestrel—Nausea—Sunitinib—kidney cancer	0.000224	0.000465	CcSEcCtD
Etonogestrel—Dyspepsia—Paclitaxel—kidney cancer	0.000223	0.000463	CcSEcCtD
Etonogestrel—Cough—Capecitabine—kidney cancer	0.000222	0.000462	CcSEcCtD
Etonogestrel—Dysuria—Doxorubicin—kidney cancer	0.00022	0.000458	CcSEcCtD
Etonogestrel—Decreased appetite—Paclitaxel—kidney cancer	0.00022	0.000457	CcSEcCtD
Etonogestrel—Hypertension—Capecitabine—kidney cancer	0.000219	0.000457	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000219	0.000455	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000218	0.000454	CcSEcCtD
Etonogestrel—Fatigue—Paclitaxel—kidney cancer	0.000218	0.000454	CcSEcCtD
Etonogestrel—Diarrhoea—Vincristine—kidney cancer	0.000218	0.000453	CcSEcCtD
Etonogestrel—Pollakiuria—Doxorubicin—kidney cancer	0.000217	0.000452	CcSEcCtD
Etonogestrel—Asthenia—Gemcitabine—kidney cancer	0.000217	0.000451	CcSEcCtD
Etonogestrel—Myalgia—Capecitabine—kidney cancer	0.000216	0.00045	CcSEcCtD
Etonogestrel—Arthralgia—Capecitabine—kidney cancer	0.000216	0.00045	CcSEcCtD
Etonogestrel—Pain—Paclitaxel—kidney cancer	0.000216	0.00045	CcSEcCtD
Etonogestrel—Constipation—Paclitaxel—kidney cancer	0.000216	0.00045	CcSEcCtD
Etonogestrel—Anxiety—Capecitabine—kidney cancer	0.000216	0.000449	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000215	0.000447	CcSEcCtD
Etonogestrel—Weight increased—Doxorubicin—kidney cancer	0.000214	0.000445	CcSEcCtD
Etonogestrel—Discomfort—Capecitabine—kidney cancer	0.000214	0.000445	CcSEcCtD
Etonogestrel—Pruritus—Gemcitabine—kidney cancer	0.000214	0.000445	CcSEcCtD
Etonogestrel—Weight decreased—Doxorubicin—kidney cancer	0.000213	0.000443	CcSEcCtD
Etonogestrel—Nausea—Dactinomycin—kidney cancer	0.000212	0.00044	CcSEcCtD
Etonogestrel—Dizziness—Vincristine—kidney cancer	0.00021	0.000438	CcSEcCtD
Etonogestrel—Infestation NOS—Doxorubicin—kidney cancer	0.00021	0.000436	CcSEcCtD
Etonogestrel—Infestation—Doxorubicin—kidney cancer	0.00021	0.000436	CcSEcCtD
Etonogestrel—Feeling abnormal—Paclitaxel—kidney cancer	0.000208	0.000433	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—RAF1—kidney cancer	0.000208	0.00241	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—CDKN1B—kidney cancer	0.000208	0.00241	CbGpPWpGaD
Etonogestrel—Oedema—Capecitabine—kidney cancer	0.000207	0.000432	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—kidney cancer	0.000207	0.0024	CbGpPWpGaD
Etonogestrel—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000207	0.00043	CcSEcCtD
Etonogestrel—Diarrhoea—Gemcitabine—kidney cancer	0.000207	0.00043	CcSEcCtD
Etonogestrel—Infection—Capecitabine—kidney cancer	0.000206	0.000429	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000206	0.000428	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—ERBB2—kidney cancer	0.000205	0.00238	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	0.000205	0.00238	CbGpPWpGaD
Etonogestrel—Urinary tract infection—Doxorubicin—kidney cancer	0.000204	0.000424	CcSEcCtD
Etonogestrel—Nervous system disorder—Capecitabine—kidney cancer	0.000203	0.000423	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—IL2—kidney cancer	0.000203	0.00236	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HARS—kidney cancer	0.000203	0.00236	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—MTOR—kidney cancer	0.000203	0.00235	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—CCND1—kidney cancer	0.000203	0.00235	CbGpPWpGaD
Etonogestrel—Vomiting—Vincristine—kidney cancer	0.000202	0.000421	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—JUN—kidney cancer	0.000202	0.00235	CbGpPWpGaD
Etonogestrel—Skin disorder—Capecitabine—kidney cancer	0.000202	0.000419	CcSEcCtD
Etonogestrel—Urticaria—Paclitaxel—kidney cancer	0.000201	0.000418	CcSEcCtD
Etonogestrel—Rash—Vincristine—kidney cancer	0.000201	0.000418	CcSEcCtD
Etonogestrel—Dermatitis—Vincristine—kidney cancer	0.0002	0.000417	CcSEcCtD
Etonogestrel—Abdominal pain—Paclitaxel—kidney cancer	0.0002	0.000416	CcSEcCtD
Etonogestrel—Body temperature increased—Paclitaxel—kidney cancer	0.0002	0.000416	CcSEcCtD
Etonogestrel—Headache—Vincristine—kidney cancer	0.000199	0.000415	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—CCND1—kidney cancer	0.000198	0.0023	CbGpPWpGaD
Etonogestrel—Anorexia—Capecitabine—kidney cancer	0.000198	0.000411	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—JUN—kidney cancer	0.000198	0.00229	CbGpPWpGaD
Etonogestrel—Sinusitis—Doxorubicin—kidney cancer	0.000197	0.000409	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—CTNNB1—kidney cancer	0.000196	0.00228	CbGpPWpGaD
Etonogestrel—ESR1—LKB1 signaling events—TP53—kidney cancer	0.000193	0.00223	CbGpPWpGaD
Etonogestrel—Vomiting—Gemcitabine—kidney cancer	0.000192	0.000399	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—LATS1—kidney cancer	0.000191	0.00222	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—PTEN—kidney cancer	0.000191	0.00222	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—JUNB—kidney cancer	0.000191	0.00221	CbGpPWpGaD
Etonogestrel—Rash—Gemcitabine—kidney cancer	0.00019	0.000396	CcSEcCtD
Etonogestrel—Dermatitis—Gemcitabine—kidney cancer	0.00019	0.000396	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—CDKN1B—kidney cancer	0.00019	0.00221	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—EEF2—kidney cancer	0.00019	0.0022	CbGpPWpGaD
Etonogestrel—Haemoglobin—Doxorubicin—kidney cancer	0.000189	0.000394	CcSEcCtD
Etonogestrel—Headache—Gemcitabine—kidney cancer	0.000189	0.000394	CcSEcCtD
Etonogestrel—Nausea—Vincristine—kidney cancer	0.000189	0.000393	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000189	0.000393	CcSEcCtD
Etonogestrel—Rhinitis—Doxorubicin—kidney cancer	0.000189	0.000393	CcSEcCtD
Etonogestrel—Haemorrhage—Doxorubicin—kidney cancer	0.000188	0.000392	CcSEcCtD
Etonogestrel—Insomnia—Capecitabine—kidney cancer	0.000188	0.00039	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—CCND1—kidney cancer	0.000187	0.00217	CbGpPWpGaD
Etonogestrel—Hypoaesthesia—Doxorubicin—kidney cancer	0.000187	0.00039	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—MAPK3—kidney cancer	0.000187	0.00217	CbGpPWpGaD
Etonogestrel—Pharyngitis—Doxorubicin—kidney cancer	0.000187	0.000389	CcSEcCtD
Etonogestrel—Paraesthesia—Capecitabine—kidney cancer	0.000186	0.000388	CcSEcCtD
Etonogestrel—Hypersensitivity—Paclitaxel—kidney cancer	0.000186	0.000388	CcSEcCtD
Etonogestrel—Urinary tract disorder—Doxorubicin—kidney cancer	0.000186	0.000387	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000185	0.00215	CbGpPWpGaD
Etonogestrel—Connective tissue disorder—Doxorubicin—kidney cancer	0.000185	0.000385	CcSEcCtD
Etonogestrel—Urethral disorder—Doxorubicin—kidney cancer	0.000185	0.000384	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000184	0.00213	CbGpPWpGaD
Etonogestrel—Dyspepsia—Capecitabine—kidney cancer	0.000183	0.00038	CcSEcCtD
Etonogestrel—PGR—Gene Expression—TET2—kidney cancer	0.000182	0.00211	CbGpPWpGaD
Etonogestrel—Visual impairment—Doxorubicin—kidney cancer	0.000181	0.000377	CcSEcCtD
Etonogestrel—Asthenia—Paclitaxel—kidney cancer	0.000181	0.000377	CcSEcCtD
Etonogestrel—Decreased appetite—Capecitabine—kidney cancer	0.00018	0.000375	CcSEcCtD
Etonogestrel—Nausea—Gemcitabine—kidney cancer	0.000179	0.000373	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000179	0.00208	CbGpPWpGaD
Etonogestrel—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000179	0.000373	CcSEcCtD
Etonogestrel—Fatigue—Capecitabine—kidney cancer	0.000179	0.000372	CcSEcCtD
Etonogestrel—Pruritus—Paclitaxel—kidney cancer	0.000179	0.000372	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—MAPK1—kidney cancer	0.000178	0.00207	CbGpPWpGaD
Etonogestrel—Constipation—Capecitabine—kidney cancer	0.000177	0.000369	CcSEcCtD
Etonogestrel—Pain—Capecitabine—kidney cancer	0.000177	0.000369	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TSC2—kidney cancer	0.000177	0.00205	CbGpPWpGaD
Etonogestrel—Eye disorder—Doxorubicin—kidney cancer	0.000176	0.000366	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	0.000176	0.00204	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—TSC2—kidney cancer	0.000176	0.00204	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—PTEN—kidney cancer	0.000175	0.00203	CbGpPWpGaD
Etonogestrel—Diarrhoea—Paclitaxel—kidney cancer	0.000173	0.00036	CcSEcCtD
Etonogestrel—ESR1—Gene Expression—EIF5B—kidney cancer	0.000173	0.002	CbGpPWpGaD
Etonogestrel—Feeling abnormal—Capecitabine—kidney cancer	0.000171	0.000356	CcSEcCtD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000171	0.00198	CbGpPWpGaD
Etonogestrel—Angiopathy—Doxorubicin—kidney cancer	0.000171	0.000355	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—kidney cancer	0.000171	0.00198	CbGpPWpGaD
Etonogestrel—Immune system disorder—Doxorubicin—kidney cancer	0.00017	0.000354	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Capecitabine—kidney cancer	0.00017	0.000353	CcSEcCtD
Etonogestrel—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	0.000168	0.00195	CbGpPWpGaD
Etonogestrel—Dizziness—Paclitaxel—kidney cancer	0.000167	0.000348	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—MAPK3—kidney cancer	0.000167	0.00194	CbGpPWpGaD
Etonogestrel—Alopecia—Doxorubicin—kidney cancer	0.000166	0.000346	CcSEcCtD
Etonogestrel—PGR—Gene Expression—TCEB1—kidney cancer	0.000166	0.00193	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—TCEB2—kidney cancer	0.000166	0.00193	CbGpPWpGaD
Etonogestrel—Mental disorder—Doxorubicin—kidney cancer	0.000165	0.000343	CcSEcCtD
Etonogestrel—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	0.000165	0.00191	CbGpPWpGaD
Etonogestrel—Urticaria—Capecitabine—kidney cancer	0.000165	0.000343	CcSEcCtD
Etonogestrel—Body temperature increased—Capecitabine—kidney cancer	0.000164	0.000341	CcSEcCtD
Etonogestrel—Abdominal pain—Capecitabine—kidney cancer	0.000164	0.000341	CcSEcCtD
Etonogestrel—Erythema—Doxorubicin—kidney cancer	0.000164	0.000341	CcSEcCtD
Etonogestrel—Malnutrition—Doxorubicin—kidney cancer	0.000164	0.000341	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—AMER1—kidney cancer	0.000163	0.00189	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—MYC—kidney cancer	0.000163	0.00189	CbGpPWpGaD
Etonogestrel—Flatulence—Doxorubicin—kidney cancer	0.000161	0.000336	CcSEcCtD
Etonogestrel—Tension—Doxorubicin—kidney cancer	0.000161	0.000335	CcSEcCtD
Etonogestrel—Vomiting—Paclitaxel—kidney cancer	0.000161	0.000334	CcSEcCtD
Etonogestrel—Rash—Paclitaxel—kidney cancer	0.000159	0.000332	CcSEcCtD
Etonogestrel—Dermatitis—Paclitaxel—kidney cancer	0.000159	0.000331	CcSEcCtD
Etonogestrel—Nervousness—Doxorubicin—kidney cancer	0.000159	0.000331	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—MAPK1—kidney cancer	0.000159	0.00185	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—MYC—kidney cancer	0.000159	0.00184	CbGpPWpGaD
Etonogestrel—Back pain—Doxorubicin—kidney cancer	0.000158	0.00033	CcSEcCtD
Etonogestrel—Headache—Paclitaxel—kidney cancer	0.000158	0.00033	CcSEcCtD
Etonogestrel—Muscle spasms—Doxorubicin—kidney cancer	0.000158	0.000328	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000155	0.0018	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—KIT—kidney cancer	0.000155	0.0018	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—MAPK3—kidney cancer	0.000154	0.00179	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Capecitabine—kidney cancer	0.000153	0.000318	CcSEcCtD
Etonogestrel—Ill-defined disorder—Doxorubicin—kidney cancer	0.000152	0.000316	CcSEcCtD
Etonogestrel—Nausea—Paclitaxel—kidney cancer	0.00015	0.000312	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—MAPK3—kidney cancer	0.00015	0.00174	CbGpPWpGaD
Etonogestrel—Asthenia—Capecitabine—kidney cancer	0.000149	0.00031	CcSEcCtD
Etonogestrel—Malaise—Doxorubicin—kidney cancer	0.000148	0.000307	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—MAPK1—kidney cancer	0.000147	0.00171	CbGpPWpGaD
Etonogestrel—Pruritus—Capecitabine—kidney cancer	0.000147	0.000305	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—BRAF—kidney cancer	0.000147	0.0017	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CDH1—kidney cancer	0.000144	0.00167	CbGpPWpGaD
Etonogestrel—Cough—Doxorubicin—kidney cancer	0.000143	0.000298	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—MAPK1—kidney cancer	0.000142	0.00165	CbGpPWpGaD
Etonogestrel—Convulsion—Doxorubicin—kidney cancer	0.000142	0.000295	CcSEcCtD
Etonogestrel—Diarrhoea—Capecitabine—kidney cancer	0.000142	0.000295	CcSEcCtD
Etonogestrel—Hypertension—Doxorubicin—kidney cancer	0.000141	0.000294	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	0.000141	0.00164	CbGpPWpGaD
Etonogestrel—Arthralgia—Doxorubicin—kidney cancer	0.000139	0.00029	CcSEcCtD
Etonogestrel—Myalgia—Doxorubicin—kidney cancer	0.000139	0.00029	CcSEcCtD
Etonogestrel—Anxiety—Doxorubicin—kidney cancer	0.000139	0.000289	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000139	0.000288	CcSEcCtD
Etonogestrel—Discomfort—Doxorubicin—kidney cancer	0.000138	0.000287	CcSEcCtD
Etonogestrel—Dizziness—Capecitabine—kidney cancer	0.000137	0.000285	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—GPC3—kidney cancer	0.000136	0.00158	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CER1—kidney cancer	0.000136	0.00158	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000136	0.00158	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—RPL14—kidney cancer	0.000135	0.00157	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—KRAS—kidney cancer	0.000134	0.00156	CbGpPWpGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000134	0.00156	CbGpPWpGaD
Etonogestrel—Anaphylactic shock—Doxorubicin—kidney cancer	0.000134	0.000278	CcSEcCtD
Etonogestrel—Oedema—Doxorubicin—kidney cancer	0.000134	0.000278	CcSEcCtD
Etonogestrel—Infection—Doxorubicin—kidney cancer	0.000133	0.000276	CcSEcCtD
Etonogestrel—ESR1—Signaling Pathways—OR4C13—kidney cancer	0.000132	0.00153	CbGpPWpGaD
Etonogestrel—Vomiting—Capecitabine—kidney cancer	0.000132	0.000274	CcSEcCtD
Etonogestrel—Nervous system disorder—Doxorubicin—kidney cancer	0.000131	0.000273	CcSEcCtD
Etonogestrel—Rash—Capecitabine—kidney cancer	0.000131	0.000272	CcSEcCtD
Etonogestrel—Dermatitis—Capecitabine—kidney cancer	0.000131	0.000272	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—TP53—kidney cancer	0.00013	0.00151	CbGpPWpGaD
Etonogestrel—Headache—Capecitabine—kidney cancer	0.00013	0.00027	CcSEcCtD
Etonogestrel—Skin disorder—Doxorubicin—kidney cancer	0.00013	0.00027	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000129	0.0015	CbGpPWpGaD
Etonogestrel—Anorexia—Doxorubicin—kidney cancer	0.000127	0.000265	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—PIK3CA—kidney cancer	0.000124	0.00143	CbGpPWpGaD
Etonogestrel—Nausea—Capecitabine—kidney cancer	0.000123	0.000256	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000122	0.000254	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—RAF1—kidney cancer	0.000122	0.00141	CbGpPWpGaD
Etonogestrel—Insomnia—Doxorubicin—kidney cancer	0.000121	0.000252	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—ERBB2—kidney cancer	0.000121	0.0014	CbGpPWpGaD
Etonogestrel—Paraesthesia—Doxorubicin—kidney cancer	0.00012	0.00025	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MTOR—kidney cancer	0.00012	0.00139	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—MTOR—kidney cancer	0.000119	0.00138	CbGpPWpGaD
Etonogestrel—Somnolence—Doxorubicin—kidney cancer	0.000119	0.000247	CcSEcCtD
Etonogestrel—Dyspepsia—Doxorubicin—kidney cancer	0.000118	0.000245	CcSEcCtD
Etonogestrel—Decreased appetite—Doxorubicin—kidney cancer	0.000116	0.000242	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—SFRP2—kidney cancer	0.000116	0.00134	CbGpPWpGaD
Etonogestrel—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000115	0.00024	CcSEcCtD
Etonogestrel—Fatigue—Doxorubicin—kidney cancer	0.000115	0.00024	CcSEcCtD
Etonogestrel—Pain—Doxorubicin—kidney cancer	0.000114	0.000238	CcSEcCtD
Etonogestrel—Constipation—Doxorubicin—kidney cancer	0.000114	0.000238	CcSEcCtD
Etonogestrel—ESR1—Signaling Pathways—LATS1—kidney cancer	0.000112	0.0013	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—JUNB—kidney cancer	0.000112	0.0013	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—CDKN1B—kidney cancer	0.000112	0.0013	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—EEF2—kidney cancer	0.000111	0.00129	CbGpPWpGaD
Etonogestrel—Feeling abnormal—Doxorubicin—kidney cancer	0.00011	0.000229	CcSEcCtD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.00011	0.00128	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—EIF4EBP1—kidney cancer	0.00011	0.00128	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—HSPB1—kidney cancer	0.00011	0.00128	CbGpPWpGaD
Etonogestrel—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000109	0.000228	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—kidney cancer	0.000107	0.00124	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—JUN—kidney cancer	0.000107	0.00124	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—TET2—kidney cancer	0.000107	0.00124	CbGpPWpGaD
Etonogestrel—Urticaria—Doxorubicin—kidney cancer	0.000106	0.000221	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	0.000106	0.00123	CbGpPWpGaD
Etonogestrel—Body temperature increased—Doxorubicin—kidney cancer	0.000106	0.00022	CcSEcCtD
Etonogestrel—Abdominal pain—Doxorubicin—kidney cancer	0.000106	0.00022	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—PTEN—kidney cancer	0.000103	0.0012	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PTEN—kidney cancer	0.000103	0.00119	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PSMD7—kidney cancer	0.000102	0.00119	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000101	0.00118	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000101	0.00118	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.0001	0.00116	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Doxorubicin—kidney cancer	9.85e-05	0.000205	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	9.82e-05	0.00114	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—TCEB2—kidney cancer	9.75e-05	0.00113	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—TCEB1—kidney cancer	9.75e-05	0.00113	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTT1—kidney cancer	9.69e-05	0.00112	CbGpPWpGaD
Etonogestrel—Asthenia—Doxorubicin—kidney cancer	9.59e-05	0.0002	CcSEcCtD
Etonogestrel—ESR1—Signaling Pathways—AMER1—kidney cancer	9.54e-05	0.00111	CbGpPWpGaD
Etonogestrel—Pruritus—Doxorubicin—kidney cancer	9.46e-05	0.000197	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—CASP2—kidney cancer	9.34e-05	0.00108	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKAP13—kidney cancer	9.34e-05	0.00108	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	9.33e-05	0.00108	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	9.3e-05	0.00108	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—JUNB—kidney cancer	9.19e-05	0.00107	CbGpPWpGaD
Etonogestrel—Diarrhoea—Doxorubicin—kidney cancer	9.15e-05	0.00019	CcSEcCtD
Etonogestrel—ESR1—Generic Transcription Pathway—CDKN2B—kidney cancer	9.12e-05	0.00106	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—PTGS1—kidney cancer	9.08e-05	0.00105	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	8.87e-05	0.00103	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	8.85e-05	0.00103	CbGpPWpGaD
Etonogestrel—Dizziness—Doxorubicin—kidney cancer	8.84e-05	0.000184	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	8.78e-05	0.00102	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—MAPK3—kidney cancer	8.78e-05	0.00102	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—kidney cancer	8.58e-05	0.000996	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	8.56e-05	0.000993	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GRB7—kidney cancer	8.54e-05	0.000991	CbGpPWpGaD
Etonogestrel—Vomiting—Doxorubicin—kidney cancer	8.5e-05	0.000177	CcSEcCtD
Etonogestrel—Rash—Doxorubicin—kidney cancer	8.43e-05	0.000175	CcSEcCtD
Etonogestrel—Dermatitis—Doxorubicin—kidney cancer	8.42e-05	0.000175	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	8.4e-05	0.000975	CbGpPWpGaD
Etonogestrel—Headache—Doxorubicin—kidney cancer	8.38e-05	0.000174	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—MAPK1—kidney cancer	8.35e-05	0.00097	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	8.21e-05	0.000953	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CER1—kidney cancer	8e-05	0.000928	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GPC3—kidney cancer	8e-05	0.000928	CbGpPWpGaD
Etonogestrel—Nausea—Doxorubicin—kidney cancer	7.94e-05	0.000165	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—ITPR2—kidney cancer	7.94e-05	0.000922	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—kidney cancer	7.93e-05	0.000921	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—RPL14—kidney cancer	7.93e-05	0.00092	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—KRAS—kidney cancer	7.89e-05	0.000916	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	7.73e-05	0.000897	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—CDKN2B—kidney cancer	7.48e-05	0.000868	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	7.31e-05	0.000849	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PIK3CA—kidney cancer	7.25e-05	0.000841	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CTNNA1—kidney cancer	7.2e-05	0.000836	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HSPB1—kidney cancer	7.16e-05	0.000831	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EIF4EBP1—kidney cancer	7.16e-05	0.000831	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	7.11e-05	0.000826	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—kidney cancer	7.05e-05	0.000818	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	6.96e-05	0.000808	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SFRP2—kidney cancer	6.8e-05	0.000789	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTP1—kidney cancer	6.72e-05	0.000779	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ANXA1—kidney cancer	6.65e-05	0.000772	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PSMD7—kidney cancer	6.65e-05	0.000772	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TSC1—kidney cancer	6.65e-05	0.000772	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	6.62e-05	0.000769	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	6.57e-05	0.000763	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HSPB1—kidney cancer	6.46e-05	0.00075	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—EIF4EBP1—kidney cancer	6.46e-05	0.00075	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FLT1—kidney cancer	6.45e-05	0.000748	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTM1—kidney cancer	6.17e-05	0.000716	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	6.09e-05	0.000706	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	6.04e-05	0.000701	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—MYC—kidney cancer	6.02e-05	0.000699	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PSMD7—kidney cancer	6.01e-05	0.000697	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—JUNB—kidney cancer	5.97e-05	0.000693	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PAK1—kidney cancer	5.97e-05	0.000693	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	5.85e-05	0.000679	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	5.84e-05	0.000678	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	5.77e-05	0.00067	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKAP13—kidney cancer	5.48e-05	0.000636	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CASP2—kidney cancer	5.48e-05	0.000636	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—JUNB—kidney cancer	5.39e-05	0.000626	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ACY1—kidney cancer	5.15e-05	0.000597	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GRB7—kidney cancer	5.01e-05	0.000582	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF2—kidney cancer	4.88e-05	0.000567	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN2B—kidney cancer	4.86e-05	0.000564	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF1R—kidney cancer	4.72e-05	0.000548	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ITPR2—kidney cancer	4.66e-05	0.000541	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—CDKN2B—kidney cancer	4.39e-05	0.000509	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PDHB—kidney cancer	4.38e-05	0.000508	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—POMC—kidney cancer	4.36e-05	0.000506	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CTNNA1—kidney cancer	4.23e-05	0.00049	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EIF4EBP1—kidney cancer	4.2e-05	0.000488	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HSPB1—kidney cancer	4.2e-05	0.000488	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CCBL1—kidney cancer	4.11e-05	0.000477	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PSMD7—kidney cancer	3.91e-05	0.000453	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ANXA1—kidney cancer	3.91e-05	0.000453	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TSC1—kidney cancer	3.91e-05	0.000453	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HIF1A—kidney cancer	3.89e-05	0.000451	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TSC2—kidney cancer	3.88e-05	0.00045	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FLT1—kidney cancer	3.78e-05	0.000439	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KDR—kidney cancer	3.72e-05	0.000432	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPAT—kidney cancer	3.57e-05	0.000414	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GLIPR1—kidney cancer	3.57e-05	0.000414	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—MYC—kidney cancer	3.53e-05	0.00041	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—JUNB—kidney cancer	3.51e-05	0.000407	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PAK1—kidney cancer	3.51e-05	0.000407	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KIT—kidney cancer	3.43e-05	0.000397	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APC—kidney cancer	3.43e-05	0.000397	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—FH—kidney cancer	3.32e-05	0.000385	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APRT—kidney cancer	3.32e-05	0.000385	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—POMC—kidney cancer	3.26e-05	0.000378	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—BRAF—kidney cancer	3.22e-05	0.000374	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GPC3—kidney cancer	3.12e-05	0.000362	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CA2—kidney cancer	3.03e-05	0.000352	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MAPK3—kidney cancer	2.98e-05	0.000346	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALAD—kidney cancer	2.96e-05	0.000343	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MYC—kidney cancer	2.9e-05	0.000336	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.88e-05	0.000335	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF2—kidney cancer	2.87e-05	0.000333	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN2B—kidney cancer	2.85e-05	0.000331	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.82e-05	0.000327	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF1R—kidney cancer	2.77e-05	0.000322	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PGK1—kidney cancer	2.7e-05	0.000314	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.7e-05	0.000314	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RAF1—kidney cancer	2.69e-05	0.000312	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RELA—kidney cancer	2.68e-05	0.000311	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ERBB2—kidney cancer	2.66e-05	0.000309	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—LDHB—kidney cancer	2.65e-05	0.000308	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MTOR—kidney cancer	2.62e-05	0.000305	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN1B—kidney cancer	2.46e-05	0.000286	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL2—kidney cancer	2.41e-05	0.00028	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCND1—kidney cancer	2.35e-05	0.000273	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—JUN—kidney cancer	2.34e-05	0.000272	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CTNNB1—kidney cancer	2.33e-05	0.00027	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CA9—kidney cancer	2.3e-05	0.000267	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HIF1A—kidney cancer	2.28e-05	0.000265	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TSC2—kidney cancer	2.28e-05	0.000264	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTEN—kidney cancer	2.27e-05	0.000263	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KDR—kidney cancer	2.18e-05	0.000253	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—kidney cancer	2.05e-05	0.000238	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APC—kidney cancer	2.01e-05	0.000233	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KIT—kidney cancer	2.01e-05	0.000233	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CRABP1—kidney cancer	1.95e-05	0.000227	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAPK3—kidney cancer	1.94e-05	0.000225	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—POMC—kidney cancer	1.91e-05	0.000222	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—BRAF—kidney cancer	1.89e-05	0.000219	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MYC—kidney cancer	1.88e-05	0.000219	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAPK1—kidney cancer	1.84e-05	0.000214	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ITPR2—kidney cancer	1.82e-05	0.000211	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MAPK3—kidney cancer	1.75e-05	0.000203	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KRAS—kidney cancer	1.74e-05	0.000202	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MYC—kidney cancer	1.7e-05	0.000197	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTT1—kidney cancer	1.66e-05	0.000192	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ACHE—kidney cancer	1.66e-05	0.000192	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CA—kidney cancer	1.6e-05	0.000186	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RAF1—kidney cancer	1.58e-05	0.000183	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RELA—kidney cancer	1.57e-05	0.000182	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SCARB1—kidney cancer	1.57e-05	0.000182	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ERBB2—kidney cancer	1.56e-05	0.000181	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTGS1—kidney cancer	1.55e-05	0.00018	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—kidney cancer	1.55e-05	0.00018	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MTOR—kidney cancer	1.54e-05	0.000179	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PSMD7—kidney cancer	1.52e-05	0.000177	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN1B—kidney cancer	1.45e-05	0.000168	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—BCHE—kidney cancer	1.44e-05	0.000168	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.43e-05	0.000165	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL2—kidney cancer	1.41e-05	0.000164	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCND1—kidney cancer	1.38e-05	0.00016	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.38e-05	0.00016	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—JUN—kidney cancer	1.38e-05	0.00016	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CTNNB1—kidney cancer	1.37e-05	0.000158	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTEN—kidney cancer	1.33e-05	0.000154	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—kidney cancer	1.2e-05	0.00014	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTP1—kidney cancer	1.15e-05	0.000133	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAPK3—kidney cancer	1.14e-05	0.000132	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MYC—kidney cancer	1.11e-05	0.000128	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCB1—kidney cancer	1.09e-05	0.000126	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAPK1—kidney cancer	1.08e-05	0.000126	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTM1—kidney cancer	1.06e-05	0.000122	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KRAS—kidney cancer	1.02e-05	0.000119	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP1A1—kidney cancer	1e-05	0.000116	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CA—kidney cancer	9.39e-06	0.000109	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—kidney cancer	9.08e-06	0.000105	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—POMC—kidney cancer	7.46e-06	8.66e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTGS2—kidney cancer	5.95e-06	6.91e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTEN—kidney cancer	5.19e-06	6.02e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CA—kidney cancer	3.66e-06	4.25e-05	CbGpPWpGaD
